No connection

Search Results

DVA vs TEM

DVA
DaVita Inc.
NEUTRAL
Price
$151.85
Market Cap
$10.01B
Sector
Healthcare
AI Confidence
85%
TEM
Tempus AI, Inc.
BEARISH
Price
$56.78
Market Cap
$10.19B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
DVA
15.97
TEM
--
Forward P/E
DVA
9.26
TEM
-628.03
P/B Ratio
DVA
-15.99
TEM
20.58
P/S Ratio
DVA
0.73
TEM
8.01
EV/EBITDA
DVA
8.77
TEM
-62.52

Profitability

Gross Margin
DVA
32.26%
TEM
62.74%
Operating Margin
DVA
15.23%
TEM
-16.7%
Profit Margin
DVA
5.47%
TEM
-19.27%
ROE
DVA
64.85%
TEM
-89.48%
ROA
DVA
7.32%
TEM
-9.66%

Growth

Revenue Growth
DVA
9.9%
TEM
83.0%
Earnings Growth
DVA
6.5%
TEM
--

Financial Health

Debt/Equity
DVA
11.11
TEM
2.7
Current Ratio
DVA
1.29
TEM
3.13
Quick Ratio
DVA
1.17
TEM
2.88

Dividends

Dividend Yield
DVA
--
TEM
--
Payout Ratio
DVA
0.0%
TEM
0.0%

AI Verdict

DVA NEUTRAL

DaVita Inc. presents a dichotomy between attractive valuation and precarious financial leverage, anchored by a stable but mediocre Piotroski F-Score of 4/9. While the stock trades at a compelling Forward P/E of 9.26 and a PEG ratio of 0.56, suggesting significant undervaluation relative to growth, this is offset by an extreme Debt/Equity ratio of 11.11 and negative book value. Bearish insider sentiment, characterized by a $199.94M sale, and a weak technical trend (10/100) further temper the bullish case. The stock is currently trading very close to its analyst target price and intrinsic value, leaving limited immediate upside.

Strengths
Highly attractive valuation with a Forward P/E of 9.26
Strong growth efficiency indicated by a PEG ratio of 0.56
Consistent historical track record of earnings beats over 25 quarters
Risks
Extreme financial leverage with a Debt/Equity ratio of 11.11
Negative Price/Book ratio (-15.99) indicating negative shareholder equity
Strongly bearish insider activity with significant recent selling
TEM BEARISH

Tempus AI exhibits critical financial fragility, highlighted by a Piotroski F-Score of 1/9, indicating severe weakness across profitability and operational efficiency. While the company demonstrates explosive revenue growth of 83% YoY, this is offset by deep negative margins and a high Debt/Equity ratio of 2.70. The bearish outlook is further reinforced by aggressive insider selling, including significant divestments by the CEO and CFO, and a technical trend score of 0/100. Despite analyst optimism, the fundamental health metrics suggest a high-risk profile.

Strengths
Exceptional YoY revenue growth of 83.00%
Strong Q/Q revenue growth of 82.98%
Healthy liquidity with a Current Ratio of 3.13
Risks
Critical financial health (Piotroski F-Score 1/9)
Heavy insider selling totaling $43.97M with zero insider buys
High leverage with a Debt/Equity ratio of 2.70

Compare Another Pair

DVA vs TEM: Head-to-Head Comparison

This page compares DaVita Inc. (DVA) and Tempus AI, Inc. (TEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile